Filing Details

Accession Number:
0000897069-23-001265
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-08-24 17:38:43
Reporting Period:
2023-08-07
Accepted Time:
2023-08-24 17:38:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1904286 Mira Pharmaceuticals Inc. MIRA Pharmaceutical Preparations (2834) 853354547
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1986372 George Cappy C/O Mira Pharmaceuticals, Inc.
900 West Platt Street, Suite 200
Tampa FL 33606-2173
No No No No
1986593 Trust Shore Bay C/O Mira Pharmaceuticals, Inc.
900 West Platt Street, Suite 200
Tampa FL 33606-2173
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-08-07 119,048 $7.00 2,859,318 No 4 P Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 20,000 Direct
Footnotes
  1. These securities are owned directly by the Bay Shore Trust (the "Trust"), a greater-than-10% owner of the Issuer. As sole trustee of the Trust, George Cappy ("Mr. Cappy") has sole ownership and dispositive power over these securities and is therefore deemed to be an indirect beneficial owner of the securities for purposes of SEC Rule 13d-3, although Mr. Cappy disclaims beneficial ownership of the reported securities due to the absence of any pecuniary interest therein.
  2. These securities are owned directly by Mr. Cappy.